Analyst firms · H.C. Wainwright · DVAX
H.C. Wainwright DVAX price target and rating history
Dynavax Technologies Corporation (DVAX) · Health Care
H.C. Wainwright rates Dynavax Technologies Corporation (DVAX) Buy with a $28 price target, as of its latest action on Dec 29, 2021. It has published 3 rating actions on DVAX since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $28
- Median target, all firms
- Too few
- Actions on DVAX
- 3
H.C. Wainwright price target on DVAX
Every H.C. Wainwright rating on DVAX
- Dec 29, 2021
- Aug 31, 2021
- Aug 5, 2021
Questions about H.C. Wainwright and DVAX
- What is H.C. Wainwright's price target for DVAX?
- H.C. Wainwright's latest stated price target for Dynavax Technologies Corporation (DVAX) is $28, from its action on Dec 29, 2021.
- What is H.C. Wainwright's rating on DVAX?
- H.C. Wainwright rates DVAX Buy, a bullish rating, as of Dec 29, 2021.
- When did H.C. Wainwright last change its view on DVAX?
- On Dec 29, 2021, H.C. Wainwright raises its price target to $28 from $23, keeps Buy.
More DVAX rating histories
All H.C. Wainwright ratingsDVAX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.